Cayuga Cancer Center — Ithaca, New York

Cayuga Cancer Center is a clinical research site located in Ithaca, New York, United States 14850.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Cayuga Cancer Center has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Advanced Solid Tumors Cancer, MSI-H Cancer, Chronic Lymphocytic Leukemia.

Sponsors: Nimbus Wadjet, Inc., Eli Lilly and Company, Kartos Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cayuga Cancer Center?

Cayuga Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cayuga Cancer Center conducted?

Cayuga Cancer Center has 5 clinical trials on record, with 5 currently active. Their work covers Advanced Solid Tumors Cancer, MSI-H Cancer, Chronic Lymphocytic Leukemia.

Is Cayuga Cancer Center accredited by Crixeo Health?

Yes — Cayuga Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cayuga Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.